Aims Molecular Science


aims

Aim and Scope

The Aims Molecular Science is a research journal that publishes quality research. This journal is published by the AIMS Press. The ISSN of this journal is NA. The E-ISSN of this journal is 2372-0301

Also, please check the following important details about aims molecular science: Publisher, ISSN, Ranking, Indexing, Impact Factor (if applicable), Publication fee (APC), Review Time, and Acceptance Rate.

According to Clarivate's JCR, journals indexed in SCIE/SSCI have an impact factor.

The ISSN (International Standard Serial Number) is an 8-digit code used to uniquely identify journals. ISSN numbers are assigned by a network of ISSN National Centres, usually located at national libraries and coordinated by the ISSN International Centre based in Paris. The International Centre is an intergovernmental organization created in 1974 through an agreement between UNESCO and the French government.

Important Metrics

Journal Title: AIMS Molecular Science
Publisher: AIMS Press
ISSN: NA
E-ISSN: 2372-0301
Current UGC CARE Status: UGC CARE Approved
UGC Coverage: from June - 2019 to Present

Indexing

The aims molecular science is indexed in:

An indexed journal means that the journal has gone through and passed a review process of certain requirements done by a journal indexer.

The Web of Science Core Collection includes the Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts & Humanities Citation Index (AHCI), and Emerging Sources Citation Index (ESCI).

Note: ESCI journals donot come with an impact factor. However, ESCI journals are evaluated every year and those who qualified are transferred to SCIE.


Aims Molecular Science Impact Factor 2024

The latest impact factor of aims molecular science is 0.7 which is recently updated in June, 2024.

The impact factor (IF) is a measure of the frequency with which the average article in a journal has been cited in a particular year. It is used to measure the importance or rank of a journal by calculating the times it's articles are cited.

Note: Every year, The Clarivate releases the Journal Citation Report (JCR). The JCR provides information about academic journals including impact factor. The latest JCR was released in June, 2023. The JCR 2024 will be released in the June 2024.


Publication fee

According to journal website, the publication fee of aims molecular science is around 500 USD.

An article processing charge (APC), also known as a publication fee, is a fee which is sometimes charged to authors. Most commonly, it is involved in making a work available as open access (OA), in either a full OA journal or in a hybrid journal.


Journal Publication Time

The Journal Publication Time means the average number of weeks between article submission and publication. According to the journal website, the aims molecular science publishes research articles in 8 weeks on an average.



Call for Papers

Visit to the official website of the journal/ conference to check the details about call for papers.

How to publish in Aims Molecular Science?

If your research is related to the scope of the journal, then visit the official website of aims molecular science and send your manuscript.

Tips for publishing in Aims Molecular Science:

Acceptance Rate

Acceptance rate is the ratio of the number of articles submitted to the number of articles published. Researchers can check the acceptance rate on the journal website. Alternatively, they can contact the editor of the journal.

Final Summary

  • The impact factor of aims molecular science is 0.7.
  • The aims molecular science is a reputed research journal.
  • It is published by AIMS Press.
  • The journal is indexed in UGC CARE, ESCI, DOAJ.
  • It is an open access journal.
  • The publication time (Average number of weeks between article submission and publication) of the journal is 8 weeks.
  • The Publication fee (APC) of aims molecular science 500 USD.

Sources: http://www.aimspress.com/journal/Molecular







TOP RESEARCH JOURNALS

Credit and Source: Scopus, Clarivate, UGC CARE.